DNMT3B and atherosclerosis: In human atherosclerotic arteries, there was a negative correlation between DNMT3B and CREG expression levels, indicating blocking CREG methylation may represent a novel therapeutic approach to treat ox-LDL-induced atherosclerosis [37].